Chargement...

Robocath and Rennes University Hospital launch co-development research program into treatment of strokes in partnership with Philips France

7 July 2021

Rouen and Rennes, France, July 7, 2021 – Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims.

With the support of Philips France, this unique program will be implemented over the next four years. It will focus on the use of robotics in treating strokes, the second most common cause of death…

Learn more

Robocath successfully completes first robotic coronary angioplasties in Belgium

4 May 2021

Rouen, France, May 04, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. The Percutaneous Coronary Interventions (PCI) were performed on April 8 and 13 by Prof. Stefan Verheye, a recognized and highly experienced interventional cardiologist at ZNA Middelheim hospital in Antwerp, and his team.  Robotic-assisted PCI has never been done before in this country.

R-One is…

Learn more
Subscribe to our newsletter